Home » Resource Center » Biotech Managed IT » What should a biotech company look for in a managed IT services provider?
What should a biotech company look for in a managed IT services provider?
Biotech companies should choose managed IT providers that support research environments, cloud infrastructure, Microsoft 365, compliance requirements, and scalable operations. For biotech companies, these services frequently extend to laboratory systems, research infrastructure, scientific workflows, LIMS, and Electronic Laboratory Notebooks (ELN).
Table of contents
What capabilities should a managed IT services provider offer biotech companies?
A biotech MSP should provide services that support both day-to-day operations and long-term organizational growth. Core capabilities include:
- Microsoft 365 administration
- Cloud infrastructure management
- Endpoint management
- Help desk support
- Server administration
- Backup and disaster recovery
- Network management
- Strategic IT planning
Many organizations work with providers, such as Single Point of Contact, that combine managed IT, cloud, compliance, and cybersecurity expertise within a single operational model. A broad service portfolio helps reduce operational complexity as technology environments expand.
How do we know if our MSP understands biotech?
An MSP with biotech experience understands that research environments have different priorities than traditional business networks. Laboratory systems, scientific applications, regulated environments, and collaboration with external partners create unique operational requirements.
Indicators of industry experience include:
- Support for laboratory environments
- Experience with LIMS and ELN platforms
- Knowledge of Microsoft 365 security
- Experience supporting research data integrity
- Familiarity with FDA and HIPAA requirements
- Understanding of research workflows
- Experience supporting scientific organizations
Industry knowledge helps providers make decisions that support both research continuity and business operations.
What should a biotech company ask before hiring a new MSP?
Before selecting a provider, biotech companies should evaluate technical capabilities, operational processes, scalability, and industry experience.
Important questions include:
- What industries do you support?
- How are service requests prioritized?
- What response times are guaranteed?
- How are backups managed?
- How do you support cloud environments?
- What cybersecurity services are available?
- How do you support compliance initiatives?
- What strategic planning services are included?
- How do you support laboratory systems and scientific applications?
Organizations evaluating providers, such as Single Point of Contact, should compare service capabilities, reporting practices, communication processes, and long-term planning support rather than focusing only on monthly pricing. A structured evaluation helps identify providers that can grow alongside the business.
How do we choose an MSP for a regulated biotech company?
Regulated organizations should evaluate providers based on operational maturity, documentation, security practices, and experience supporting compliance-driven environments. Providers should also understand FDA 21 CFR Part 11, HIPAA, GxP-regulated environments, documentation requirements, and research data integrity.
Areas to review include:
- Change management processes
- Documentation standards
- Backup validation
- Access management
- Vendor management
- Regulatory support
- Asset management
- Business continuity planning
An MSP that understands regulated environments is better prepared to support reliable operations while helping organizations maintain consistent IT governance.
How can we tell if our current MSP is underperforming?
An underperforming MSP often shows operational warning signs before significant business problems occur.
Common indicators include:
- Slow response times
- Recurring technical issues
- Poor communication
- Frequent outages
- Incomplete documentation
- Limited strategic guidance
- Repeated security concerns
- Missed service commitments
The chart below summarizes common evaluation criteria.
Performance area | Positive indicator | Warning sign |
Help desk | Timely resolution | Growing ticket backlog |
Infrastructure | Stable systems | Repeated outages |
Communication | Regular updates | Limited visibility |
Documentation | Accurate records | Missing information |
Planning | Strategic guidance | Reactive support |
Security | Coordinated practices | Unresolved risks |
Regular performance reviews help organizations identify improvement opportunities before operational issues begin affecting researchers and employees.
How do we replace an MSP without disrupting employees?
Replacing an MSP requires planning, documentation, and a structured transition process. Organizations should inventory systems, document administrative access, review contracts, and establish clear communication before migration activities begin.
Successful transitions typically include:
- Asset inventory
- Credential review
- Documentation transfer
- Service overlap
- User communications
- Migration planning
- Knowledge transfer sessions
- Testing activities
- Post-transition support
Providers, such as Single Point of Contact, frequently follow structured onboarding processes that reduce operational disruption and facilitate knowledge transfer and the assumption of day-to-day IT responsibilities. Careful planning helps employees continue working with minimal interruption.
Why is strategic IT planning important for biotech companies?
Technology decisions should support both current operations and future growth. As organizations expand research programs, hire additional staff, adopt new cloud services, and prepare for regulatory milestones, IT requirements become more complex.
Strategic planning helps organizations:
- Prioritize technology investments
- Improve infrastructure scalability
- Support laboratory growth
- Strengthen operational resilience
- Reduce technical debt
- Align IT with business objectives
Strategic planning also helps organizations prepare for future laboratory expansion, acquisitions, and regulatory milestones. Having an IT roadmap provides a framework for making informed technology decisions that support long-term organizational success.
Choosing a managed IT provider that supports long-term growth
The best-managed IT providers deliver more than just technical support. They provide operational stability, strategic guidance, scalable infrastructure management, and expertise that supports research, collaboration, compliance, and business growth.
Organizations that evaluate providers based on industry experience, operational maturity, service quality, and long-term partnership potential are better positioned to build reliable technology foundations that evolve alongside scientific innovation.
Where can biotech companies learn more about managed security providers?
Organizations can learn how managed security services support biotech environments through Single Point of Contact’s biotech IT and security services. Services include 24×7 monitoring, threat detection, incident response, compliance support, Microsoft 365 security, and protection of research data and intellectual property.
Related Articles
Should a biotech MSP provide cybersecurity services too?
Managed IT and cybersecurity increasingly overlap, but they serve different purposes. Learn which security responsibilities belong with an MSP, when an MSSP becomes necessary, and how coordinated services reduce operational and compliance risk.
Biotech managed IT resource center
This hub provides an overview of managed IT services for biotech companies, including MSP selection, cloud infrastructure, Microsoft 365, laboratory IT, help desk support, compliance, disaster recovery, strategic IT planning, and technology guidance for growing life science organizations.
Biotech cybersecurity services overview
This page provides an overview of cybersecurity, compliance, cloud, and managed IT services for biotech companies. Learn how life sciences organizations protect research data, support laboratory environments, strengthen operational resilience, meet regulatory requirements, and align technology strategies with scientific and business objectives.
Frequently asked questions
Should a biotech company choose an MSP that also provides cybersecurity services?
Many biotech companies benefit from providers that offer both managed IT and cybersecurity services because infrastructure management and security frequently overlap. Organizations can often improve coordination, simplify vendor management, and strengthen operational consistency through an integrated service model.
How often should a biotech evaluate its MSP?
Most organizations should formally evaluate MSP performance at least annually and after significant business, regulatory, or technology changes. Regular reviews help confirm that service capabilities continue to align with operational requirements and organizational growth.
Can a small biotech benefit from a managed IT provider?
Yes. Managed IT services give smaller organizations access to experienced engineers, structured operational processes, strategic guidance, and scalable technology support without building a large internal IT department.
What should a biotech expect during MSP onboarding?
Onboarding typically includes infrastructure discovery, documentation reviews, asset inventories, administrative credential verification, monitoring deployment, user communications, and transition planning. Providers, such as Single Point of Contact, generally use structured onboarding processes to minimize disruption and establish ongoing IT operations.
How do managed IT services support business growth?
Managed IT services help organizations maintain reliable technology, improve productivity, support cloud adoption, strengthen business continuity, and build infrastructure that scales with expanding research programs, employees, and operational requirements.
Should a biotech choose one provider for managed IT and cybersecurity?
Many biotech companies prefer a provider that delivers both managed IT and cybersecurity services because infrastructure management and security operations are closely connected. A unified approach can improve communication, reduce vendor complexity, strengthen visibility across technology environments, and simplify long-term planning.
About the author
Fernando Leon is a biotech technology and services leader with experience in IT and security service delivery, pricing models, and cost evaluation. He works with biotech organizations to understand the full cost of outsourced and managed services, including operational, staffing, and infrastructure considerations. His background includes helping biotech organizations align pricing with service outcomes and long-term scalability. Fernando focuses on practical cost analysis, enabling organizations to make informed decisions based on the total cost of ownership rather than upfront pricing alone.